Tranexamic Acid in Body Contouring Surgery: A Systematic Review and Meta-Analysis
Aesthetic Surgery Journal · 16.09.2025 · 45 (10) · 1026-1034
DOI: 10.1093/asj/sjaf112 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Aesthetic Surgery Journal, online erschienen am 13.06.2025. Verfasst von Arman J Fijany und 10 weiteren Autor:innen. Hauptthemen laut MEDLINE: Tranexamic Acid, Antifibrinolytic Agents, Body Contouring, Postoperative Complications. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Breast and body contouring procedures are plastic surgery’s most popular and effective interventions. Although these procedures are generally safe, they are not without risks and complications. Antifibrinolytic drugs such as tranexamic acid (TXA) have been used as an adjunct to improve outcomes. The authors of this meta-analysis explore the impact of TXA on complications in breast and body contouring procedures. They searched PubMed (US National Library of Medicine, Bethesda, MD) for studies that used TXA in standard breast reconstruction and body contouring procedures. They then performed a meta-analysis on the following complications: hematoma, seroma, infection, and wound-healing complications. A Mantel–Haenszel method random-effects model was used to calculate the odds ratio (OR) within and a 95% CI for dichotomous outcomes. Subgroups were created for studies that utilized systemic (IV), topical or concurrent IV, and topical TXA administration. A total of 13 studies were selected and included in the analysis. There was a significant lower risk of hematoma (OR = 0.37; 95% CI = 0.18-077; P = .008) in the TXA cohort. There were no significant differences observed in terms of wound-healing issues or seroma formation. The subgroup analysis of this study demonstrated significantly decreased risks of infection (OR = 0.41; 95% CI = 0.22-077; P = .005) in the topical TXA cohort. In breast and body contouring procedures, the risk of hematoma and wound-healing complications can potentially be reduced by IV TXA administration. The infection risk can be potentially reduced by topical TXA administration. Level of Evidence: 3 (Therapeutic)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
ORCID-Profile: Arman J Fijany, Galen Perdikis, Elizabeth D Slater
Zitieren
APA
Fijany, A. J., Holan, C. A., Troia, T., Montorfano, L., Mubang, R. N., Givechian, K. B., Karagoz, H., Martinez-Jorge, J., Perdikis, G., Connor, L. M., & Slater, E. D. (2025). Tranexamic Acid in Body Contouring Surgery: A Systematic Review and Meta-Analysis. Aesthetic Surgery Journal, 45(10), 1026-1034. https://doi.org/10.1093/asj/sjaf112
Vancouver
Fijany AJ, Holan CA, Troia T, Montorfano L, Mubang RN, Givechian KB, et al. Tranexamic Acid in Body Contouring Surgery: A Systematic Review and Meta-Analysis. Aesthetic Surgery Journal. 2025;45(10):1026-1034. doi:10.1093/asj/sjaf112
BibTeX
@article{Fijany2025,
author = {Fijany, Arman J and Holan, Cole A and Troia, Thomas and Montorfano, Lisandro and Mubang, Ronnie N and Givechian, Kevin Bijan and Karagoz, Huseyin and Martinez-Jorge, Jorys and Perdikis, Galen and Connor, Lauren M and Slater, Elizabeth D},
title = {Tranexamic Acid in Body Contouring Surgery: A Systematic Review and Meta-Analysis},
journal = {Aesthetic Surgery Journal},
year = {2025},
volume = {45},
number = {10},
pages = {1026--1034},
doi = {10.1093/asj/sjaf112}
}
EUVIMED